Treatment of the aorto-iliac segment in complex lower extremity arterial occlusive disease
A Wressnegger1, C Kinstner, M Funovics
1Cardiovascular and Interventional Radiology Department of Biomedical Imaging and Image‑Guided Therapy Medical University of Vienna, Vienna, Austria - martin.funovics@meduniwien.ac.at.
Insights
Endovascular treatment is effective for aortoiliac occlusive disease, offering high patency and lower risks than surgery, especially for TASC C and D lesions in high-risk patients.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapies
Background:
- Endovascular treatment is established for TASC A and B aortoiliac occlusive disease.
- Modern stent technology yields high one-year primary patency rates (>95%).
Purpose of the Study:
- To evaluate the efficacy and safety of endovascular treatment for aortoiliac occlusive disease.
- To compare endovascular approaches (provisional vs. primary stenting) and outcomes versus open surgery.
Main Methods:
- Review of recent studies on endovascular stent technology for aortoiliac lesions.
- Analysis of evidence comparing endovascular techniques with open surgical repair.
- Assessment of outcomes including primary patency, complication rates, and mortality.
Main Results:
- One-year primary patency exceeds 95% with modern stent technology.
- Provisional stenting is supported for stenoses, while primary stenting is indicated for occlusions.
- Endovascular treatment demonstrates lower complication and mortality rates than open surgery, despite potentially lower patency.
Conclusions:
- Endovascular treatment is a viable and safe option for aortoiliac occlusive disease, including TASC C and D lesions.
- It offers a favorable risk profile, particularly for patients unsuitable for open surgery.
- Current guidelines may need revision regarding the exclusive surgical recommendation for complex lesions.
Abstract:
Endovascular treatment of the aortoiliac segment in occlusive disease has an established role especially in TASC A and B lesions. Recent studies with modern stent technology have shown excellent results with one-year primary patency above 95%. Regarding different endovascular approaches, there is level Ib evidence supporting provisional stenting in stenosed arteries, and primary stenting in occlusion. While open surgery shows higher patency rates in direct comparison to endovascular techniques, the latter show significantly lower complication rates and lower mortality. The recommendations reserving TASC C and D lesions exclusively to surgery are currently challenged, especially in poor surgical candidates.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Arteries of Lower Limbs


